Advanced Cell Diagnostics Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
150
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$325M
Advanced Cell Diagnostics General Information
Description
Operator of a biotechnology company intended to develop cell and tissue-based diagnostic tests for personalized medicine. The company offers cancer diagnostic tests including tests for breast cancer, circulating tumor cells and cervical cancer and serves pharmaceutical and biotech companies, physicians and patients, enabling clients to avail quality cell research services.
Contact Information
Website
www.acdbio.com(Operating Subsidiary)
Corporate Office
- 614 McKinley Place NorthEast
- Minneapolis, MN 55413
- United States
Advanced Cell Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 01-Aug-2016 | $325M | 000.00 | 00000 | Completed | Generating Revenue |
| 4. Later Stage VC (Series C) | 18-Jun-2015 | 0000 | 000.00 | Completed | Generating Revenue | |
| 3. Grant | 06-Oct-2014 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 2. Later Stage VC (Series B1) | 01-Nov-2012 | $12M | $17.4M | 000.00 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 02-Sep-2009 | $5.4M | $5.4M | 000.00 | Completed | Product Development |
Advanced Cell Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 6,005,338 | $0.000100 | $0.07 | $0.9 | $0.9 | 1x | $0.9 | 22.26% |
Advanced Cell Diagnostics Comparisons
Industry
Financing
Details
000000
000000
Advanced Cell Diagnostics Competitors (37)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Empire Genomics | Private Equity-Backed | Williamsville, NY | 00 | 00.000 | 000000000000 | 00.000 |
| Miltenyi Biotec | Private Debt Financed | Bergisch Gladbach, Germany | 0000 | 000000000 | ||
| Myriad Genetics | Corporation | Salt Lake City, UT | 0000 | 00000 | 00000000 | 00000 |
| Menarini Silicon Biosystems | Formerly VC-backed | Castel Maggiore, Italy | 00000 | 000.00 | 000000&0 | 000.00 |
| Caris Life Sciences | Private Equity-Backed | Irving, TX | 0000 | 00.00 | 00000000000 | 00.00 |
Advanced Cell Diagnostics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Advanced Cell Diagnostics Patents
Advanced Cell Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240035073-A1 | Methods for detecting proteins and for co-detecting proteins and nucleic acids, and kits for the same | Pending | 21-Jan-2022 | 0000000000 | 0 |
| EP-4323442-A1 | Methods and compositions for reducing autofluorescence | Pending | 16-Apr-2021 | ||
| EP-4322837-A1 | Materials and methods related to image processing | Pending | 16-Apr-2021 | 0000000000 | |
| EP-4213620-A1 | Methods and compositions for removal of rna | Pending | 18-Sep-2020 | 00000000000 | |
| US-20230313171-A1 | Methods and compositions for removal of rna | Pending | 18-Sep-2020 | C12N15/1003 |
Advanced Cell Diagnostics Executive Team (13)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Deborah Wright | Vice President, QA & Research Associate | ||
| Richard Brooks Ph.D | Senior Director, Sales |
Advanced Cell Diagnostics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Advanced Cell Diagnostics Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Kenson Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Morningside Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| New Leaf Venture | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Summit Partners | PE/Buyout | Minority | 000 0000 | 000000 0 |
Advanced Cell Diagnostics FAQs
-
When was Advanced Cell Diagnostics founded?
Advanced Cell Diagnostics was founded in 2006.
-
Who is the founder of Advanced Cell Diagnostics?
Yuling Luo Ph.D and Steve Chen Ph.D are the founders of Advanced Cell Diagnostics.
-
Where is Advanced Cell Diagnostics headquartered?
Advanced Cell Diagnostics is headquartered in Minneapolis, MN.
-
What is the size of Advanced Cell Diagnostics?
Advanced Cell Diagnostics has 150 total employees.
-
What industry is Advanced Cell Diagnostics in?
Advanced Cell Diagnostics’s primary industry is Biotechnology.
-
Is Advanced Cell Diagnostics a private or public company?
Advanced Cell Diagnostics is a Private company.
-
What is the current valuation of Advanced Cell Diagnostics?
The current valuation of Advanced Cell Diagnostics is 00000.
-
What is Advanced Cell Diagnostics’s current revenue?
The current revenue for Advanced Cell Diagnostics is 000000.
-
How much funding has Advanced Cell Diagnostics raised over time?
Advanced Cell Diagnostics has raised $39.4M.
-
Who are Advanced Cell Diagnostics’s investors?
Kenson Ventures, Morningside Group, New Leaf Venture, and Summit Partners have invested in Advanced Cell Diagnostics.
-
Who are Advanced Cell Diagnostics’s competitors?
Empire Genomics, Miltenyi Biotec, Myriad Genetics, Menarini Silicon Biosystems, and Caris Life Sciences are some of the 37 competitors of Advanced Cell Diagnostics.
-
When was Advanced Cell Diagnostics acquired?
Advanced Cell Diagnostics was acquired on 01-Aug-2016.
-
Who acquired Advanced Cell Diagnostics?
Advanced Cell Diagnostics was acquired by Bio-Techne.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
